Alex Driggs serves as Executive at Sucampo Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Alex Driggs has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 13, 2018 involved selling 6,084 shares valued at $109.5K.
Alex Driggs currently holds 6,084 shares of Sucampo Pharmaceuticals, Inc. (SCMP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alex Driggs has been a net neutral trader of SCMP stock. They have purchased $0 and sold $0 worth of shares.
Alex Driggs's most recent insider trade was on Feb 13, 2018, when they sold 6,084 shares at $18.00 per share.
Get notified when new Form 4 filings are submitted
| $9.10 |
| Discretionary |
| Dec 28, 2017 | SCMP | $36.4K | Payment | 2,025 | $17.98 | Discretionary |
| Sep 30, 2017 | SCMP | $6.0K | Award | 659 | $9.10 | Discretionary |
| Jun 30, 2017 | SCMP | $6.0K | Award | 672 | $8.93 | Discretionary |